Literature DB >> 2066428

Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma.

M M Reid1, J P Wallis, A G McGuckin, A D Pearson, A J Malcolm.   

Abstract

The ability to detect infiltration in bone marrow biopsy specimens from patients with disseminated neuroblastoma was assessed by immunohistological and routine histological methods. Frozen cores from 33 staging procedures were tested with UJ13A and UJ127.11. Immunopositive tumour cells were found in 10 of 17 staging procedures in which tumour was detectable by routine histological methods. Positive cells or stromal material were also found in eight of 12 staging procedures in which distorted architecture and fibrosis, but no obvious tumour, had been noted. Paraffin wax embedded cores from 29 of the same staging procedures were tested with antibodies against neurone specific enolase and neurofilament. Only a single core reacted with anti-neurofilament antibody. Neurone specific enolase positive cells or stromal material were found in nine of 15 staging procedures in which obvious tumour was detectable. Although these immunohistochemical techniques proved inferior to routine histology in their ability to detect obvious tumour, the demonstration of immunopositive stromal tissue which was not frankly malignant supports the view that distorted, fibrotic marrow may reflect persistence of neuroectodermal tissue and justifies its distinction from normal marrow when reporting the response to treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066428      PMCID: PMC496830          DOI: 10.1136/jcp.44.6.483

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Histology of neuroblastoma involving bone marrow.

Authors:  J W Ironside; C R Shiach; A C Cuthbert; E A Robinson
Journal:  Br J Haematol       Date:  1989-04       Impact factor: 6.998

2.  Bone marrow examination in neuroblastoma patients: a morphologic, immunocytochemical, and immunohistochemical study.

Authors:  B R Oppedal; I Storm-Mathisen; J T Kemshead; P Brandtzaeg
Journal:  Hum Pathol       Date:  1989-08       Impact factor: 3.466

3.  Histology of neuroblastoma involving bone marrow: the problem of detecting residual tumour after initiation of chemotherapy.

Authors:  M M Reid; P J Hamilton
Journal:  Br J Haematol       Date:  1988-08       Impact factor: 6.998

4.  International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

Authors:  G M Brodeur; R C Seeger; A Barrett; F Berthold; R P Castleberry; G D'Angio; B De Bernardi; A E Evans; M Favrot; A I Freeman
Journal:  J Clin Oncol       Date:  1988-12       Impact factor: 44.544

5.  Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples.

Authors:  D Beck; O Maritaz; N Gross; M Favrot; N Vultier; C Bailly; I Villa; O Gentilhomme; T Philip
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

6.  Immunohistochemical localization of neurofilaments and neuron-specific enolase in 29 cases of neuroblastoma.

Authors:  M Osborn; T Dirk; H Käser; K Weber; M Altmannsberger
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

7.  Diagnosis of neuroblastoma metastasis in bone marrow with a panel of monoclonal antibodies.

Authors:  T Sugimoto; T Sawada; T Matsumura; J T Kemshead; Y Horii; T Saida; S Imashuku; Y Takeuchi
Journal:  Med Pediatr Oncol       Date:  1988

8.  Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.

Authors:  D W Rogers; J G Treleaven; J T Kemshead; J Pritchard
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

9.  Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.

Authors:  C R Pinkerton; J M Zucker; O Hartmann; J Pritchard; V Broadbent; P Morris-Jones; F Breatnach; A E Craft; A D Pearson; K R Wallendszus
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

10.  Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.

Authors:  M C Favrot; D Frappaz; O Maritaz; I Philip; B Fontaniere; O Gentilhomme; C Bailly; J M Zucker; J C Gentet; J Kemshead
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

View more
  4 in total

1.  Detection of bone marrow metastases in neuroblastoma using a short term tissue culture technique.

Authors:  J A Adams; A M Kelsey; T F Carr; R F Stevens; P Morris-Jones
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

2.  Use of methyl methacrylate resin for embedding bone marrow trephine biopsy specimens.

Authors:  D Blythe; N M Hand; P Jackson; S L Barrans; R D Bradbury; A S Jack
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

3.  Central review of bone marrow biopsy specimens from patients with neuroblastoma.

Authors:  M M Reid; B Roald
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

4.  What is marrow fibrosis after treatment of neuroblastoma?

Authors:  G E Turner; M M Reid
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.